Menu Back to7th DIA Regulatory Communication Training Course in Japan

7th DIA Regulatory Communication Training Course in Japan

All prices are exclusive of 10% Japanese consumption tax

Overview

Japanese Language Only

Click Here to View the Flyer in Japanese.

Program Committee

  • Keisuke  Awa
    Keisuke Awa Deputy Director
    Ministry of Health, Labour and Welfare (MHLW), Japan
  • Masaharu  Doi
    Masaharu Doi Medical Writer, Associate Director
    PRA Health Sciences, Japan
  • Katsuhiko  Ichimaru
    Katsuhiko Ichimaru Review Director, Office of New Drug IV
    Pharmaceuticals and Medical Devices Agency (PMDA), Japan
  • Akiko  Ikeda, RPh
    Akiko Ikeda, RPh Associate Director, Regulatory Development Dept., Regulatory Affairs Division,
    Janssen Pharmaceutical K.K., Japan
  • Toshiko  Ishibashi, PhD, RN
    Toshiko Ishibashi, PhD, RN Associate Director,Oncology Medical Science Department
    Daiichi Sankyo Co., Ltd., Japan
  • Takaaki  Ishine
    Takaaki Ishine Senior Clinical Research Specialist
    MSD K.K., Japan
  • Yomei  Matsuoka, MSc, RPh
    Yomei Matsuoka, MSc, RPh Vice President, Pharmacoepidemiology and PMS Department
    Daiichi Sankyo Co., Ltd., Japan
  • Naomi  Misaki, MPharm
    Naomi Misaki, MPharm CRC, Research Management
    St. Luke's International Hospital, Japan
  • Hiroyuki  Murakami
    Hiroyuki Murakami Duputy Review Director, Office of New Drug I
    Pharmaceuticals and Medical Devices Agency (PMDA), Japan
  • Norikazu  Takahata
    Norikazu Takahata President
    Plus Action for Children, Japan
  • Satoshi  Takeuchi
    Satoshi Takeuchi Manager, R&D Regulatory 3, Regulatory Affairs
    Sanofi.K.K., Japan
  • Nao  Tsuchida, MD, PhD
    Nao Tsuchida, MD, PhD Chief
    National Hospital Organization Headquarters, Japan
Load More

Contact us

Please contact the DIA Japan office in Tokyo for further information.

Tel: +81-3-6214-0574
Fax: +81-3-3278-1313
Japan@DIAglobal.org
www.diajapan.org